martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 3, 2025

Stocks Recover on Fed Rate Cut Expectations

View original at nasdaq.com
Stocks Recover on Fed Rate Cut Expectations The S&P 500 Index ($SPX) (SPY) today is up by +0.18%, the Dow Jones Industrials Index ($DOWI) (DIA) is up by +0.47%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down by -0.06%…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Forecasted Q4 operating income of $220 million to $230 million, above consensus of $214.5 million

    80% confidence
  • Forecasted Q4 revenue of $251 million to $252 million, midpoint below consensus of $251.9 million

    80% confidence
  • Raised 2026 comparable sales growth forecast to low single digits from previous estimate of flat

    80% confidence
  • Upgraded Astera Labs to buy with price target of $275

    80% confidence
  • Q3 adjusted EPS forecasted at 40 cents, above consensus of 37 cents

    80% confidence
  • Upgraded Stellantis to buy from neutral with price target of $12

    80% confidence
  • Microsoft is reducing its AI software sales quotas amid consumer resistance to newer products

    80% confidence
  • Kevin Hassett is seen as the likely choice to succeed Powell as Fed Chair

    80% confidence
  • Q3 earnings rose 14.6%, more than doubling expectations of 7.2% y/y

    80% confidence
  • He will announce his selection for the new Fed Chair in early 2026

    80% confidence
  • 83% of reporting S&P 500 companies exceeded forecasts, on course for the best quarter since 2021

    80% confidence
  • Cut full-year adjusted EPS forecast to $1.94-$2.04 from previous estimate of $2.35-$2.45, well below consensus of $2.37

    80% confidence
  • Upgraded Vertex Pharmaceuticals to overweight from equal weight with price target of $516

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Stocks Recover on Fed Rate Cut Expectations — Source | Via News | es.VIA.NEWS